Last reviewed · How we verify

NCT05788315: CFITWA

The Influence of the Cultural Formulation Interview on Therapeutic Work Alliance

Status unknown NA Last updated 4 April 2023
What this trial tests

NA trial testing Cultural Formulation Interview in Therapeutic Alliance in 164 participants. Status unknown.

Timeline
1 June 2023
Primary endpoint
1 June 2024
1 December 2024

Quick facts

Lead sponsorTilburg University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment164
Start date1 June 2023
Primary completion1 June 2024
Estimated completion1 December 2024
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Tilburg University

Who can join

18 and older, any sex, with Therapeutic Alliance or Empathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The increased cultural diversity in client populations in mental healthcare settings led to the addition of the Cultural Formulation Interview (CFI) in the Diagnostic and Statistical Manual for Mental Disorders (DSM-5). The CFI aims to clarify clients' vision, experiences, and context to improve communication about cultural backgrounds, increase mutual understanding and rapport, and prevent cultural misunderstandings. Empirical evidence of this effect in clinical practice is still lacking. This study investigates whether the CFI influences the therapeutic working alliance between a client with a migration background and a clinician, and the informant version of the CFI (CFI-I) influences the relationship between a client's informant and a clinician, focusing on the role of perceived cultural empathy as moderator, or mediator in this interaction. A Cluster-Randomized Controlled Trial (RCT) will be performed among clients with a migratory background in four mental healthcare centers in the Netherlands. The participants in this study are adults with a migratory background, aged 18 years and older, their informants, and clinicians. Participants were randomly assigned into two groups. In the intervention group, the CFI and CFI-Informant version (CFI-I) were used shortly after admission and intake, and the control group received a clinical assessment as usual. Included informants were assessed with the CFI-I or hetero-anamneses by the participating clinicians. The main outcome measure is the work alliance between clients and their clinicians. This will be evaluated using the Work Alliance Questionnaire. Perceived cultural empathy as a potential mediator or moderator will be measured with the Barrett-Lennart Relationship Inventory among clients and informants, and the Scale of Ethnocultural Empathy among clinicians. The clients and informants will be randomly assigned to the intervention group or the control group. They will all fill out a questionnaire about perceived cultural empathy after the first, and two questionnaires about work alliance, and perceived cultural empathy after five treatment sessions. The clinicians will perform the clinical assessments with or without the CFI and fill out a questionnaire about self-perceived cultural empathy after the first session and two questionnaires about work alliance and cultural empathy after a maximum of five given treatments. There is no physical, behavioral, or medical intervention included in the research protocol.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effect of the cultural formulation interview on therapeutic working alliance: a study protocol.
    Brand AM, Groen SPN, Destoop N, Jongsma HE, et al · · 2024 · cited 2× · PMID 38501082 · DOI 10.3389/fpsyt.2024.1322356

Verify or expand the search:

Other trials of Cultural Formulation Interview

Trials testing the same drug.

Other recruiting trials for Therapeutic Alliance

Currently open trials in the same condition.

Other Tilburg University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05788315.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing